Perelman School of Medicine: Newly Discovered Brain Response to Obesity Drug May Inform Future Treatments
March 05, 2020
March 05, 2020
PHILADELPHIA, Pennsylvania, March 5 [TNSmedicalresearch] -- The University of Pennsylvania's Perelman School of Medicine issued the following news release:
* * *
- Penn researchers show how FDA-approved drug interacts with distinct set of neurons in the brain's "energy balance" system
* * *
The U.S. Food and Drug Administration-approved drug liraglutide has been shown to help obese patients lose weight by suppressing their appetite. H . . .
* * *
- Penn researchers show how FDA-approved drug interacts with distinct set of neurons in the brain's "energy balance" system
* * *
The U.S. Food and Drug Administration-approved drug liraglutide has been shown to help obese patients lose weight by suppressing their appetite. H . . .